Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Impact of klotho on the expression of SRGAP2a in podocytes in diabetic nephropathy

Fig. 2

SRGAP2a is involved in the TGF-β1 signalling pathways in rat podocytes. A The immunofluorescence staining of SRGAP2a in TGF-β1 interference and TGF-β1 overexpression conditions with HG treatments. B The qRT-PCR results showed that the expression of SRGAP2a in silencing TGF-β1 + HG treatment and in TGF-β1-OE + HG treatment. C The western blot results showed the SRGAP2a levels in silencing TGF-β1 + HG treatment and in TGF-β1-OE + HG treatment. D The quantitative analysis of the SRGAP2a protein levels in C) All data were mean ± SD, (n = 6); *p < 0.05, **p < 0.01. Bars = 50 μm in A

Back to article page